Healthcare provider profile · identity verified

Uma Devi Chaganti, MD

Allopathic & Osteopathic Physicians|Internal Medicine · SPRINGFIELD, MA · NPI 1609173954

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Uma Devi Chaganti, MD received $80.20 in general payments during 2025 across 3 reported records.

Exact Sciences Corporation accounted for 42.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Synthroid by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 101 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 226 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$80.20

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$34.24	42.7%	1	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$29.43	36.7%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$16.53	20.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$80.20	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$34.24	1	2025
Source payment records 2025-03-31 · Exact Sciences Corporation · $34.24 · Open Payments source
CREON Normalized: creon	Drug	ABBVIE INC.	$29.43	1	2025
Source payment records 2025-11-19 · ABBVIE INC. · $29.43 · Open Payments source
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$16.53	1	2025
Source payment records 2025-04-14 · Lilly USA, LLC · $16.53 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$16.53	1	2025
Source payment records 2025-04-14 · Lilly USA, LLC · $16.53 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	24 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	27	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	27	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	101	21
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	24	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	226	40

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	2073	521
Amlodipine Besylate	Amlodipine Besylate	1681	411
Losartan Potassium	Losartan Potassium	1158	281
Lisinopril	Lisinopril	1107	265
Omeprazole	Omeprazole	1049	265
Levothyroxine Sodium	Levothyroxine Sodium	982	226
Hydrochlorothiazide	Hydrochlorothiazide	750	195
Metformin Hcl	Metformin Hcl	657	165
Gabapentin	Gabapentin	648	149
Metoprolol Succinate	Metoprolol Succinate	544	148
Simvastatin	Simvastatin	514	133
Pantoprazole Sodium	Pantoprazole Sodium	505	112
Furosemide	Furosemide	491	119
Trazodone Hcl	Trazodone Hcl	490	121
Albuterol Sulfate Hfa	Albuterol Sulfate	456	127
Glipizide Er	Glipizide	450	100
Rosuvastatin Calcium	Rosuvastatin Calcium	369	95
Tramadol Hcl	Tramadol Hcl	343	67
Metoprolol Tartrate	Metoprolol Tartrate	342	89
Alendronate Sodium	Alendronate Sodium	330	76
Fluticasone Propionate	Fluticasone Propionate	319	101
Eliquis	Apixaban	308	68
Sertraline Hcl	Sertraline Hcl	305	77
Potassium Chloride	Potassium Chloride	295	76
Hydralazine Hcl	Hydralazine Hcl	276	66
Carvedilol	Carvedilol	268	59
Pravastatin Sodium	Pravastatin Sodium	268	73
Meloxicam	Meloxicam	259	60
Montelukast Sodium	Montelukast Sodium	247	45
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	245	83
Tamsulosin Hcl	Tamsulosin Hcl	238	58
Diclofenac Sodium	Diclofenac Sodium	231	77
Trulicity	Dulaglutide	226	40
Tizanidine Hcl	Tizanidine Hcl	216	52
Glipizide	Glipizide	207	52
Metformin Hcl Er	Metformin Hcl	198	53
Famotidine	Famotidine	195	47
Prednisone	Prednisone	185	131
Meclizine Hcl	Meclizine Hcl	180	57
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	178	48
Atenolol	Atenolol	177	45
Ibuprofen	Ibuprofen	162	48
Oxybutynin Chloride Er	Oxybutynin Chloride	161	50
Fluoxetine Hcl	Fluoxetine Hcl	157	32
Allopurinol	Allopurinol	154	37
Buspirone Hcl	Buspirone Hcl	152	39
Hydroxyzine Hcl	Hydroxyzine Hcl	151	40
Fenofibrate	Fenofibrate	150	39
Clopidogrel	Clopidogrel Bisulfate	148	38
Januvia	Sitagliptin Phosphate	146	26
Citalopram Hbr	Citalopram Hydrobromide	139	33
Ketoconazole	Ketoconazole	132	40
Mirtazapine	Mirtazapine	128	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	125	37
Isosorbide Mononitrate Er	Isosorbide Mononitrate	120	26
Amitriptyline Hcl	Amitriptyline Hcl	117	24
Duloxetine Hcl	Duloxetine Hcl	117	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	116	21
Celecoxib	Celecoxib	115	28
Donepezil Hcl	Donepezil Hcl	113	22
Clonazepam	Clonazepam	112	18
Ezetimibe	Ezetimibe	110	28
Lorazepam	Lorazepam	110	36
Valsartan	Valsartan	110	27
Spironolactone	Spironolactone	107	28
Hydrocortisone	Hydrocortisone	103	50
Jardiance	Empagliflozin	101	21
Paroxetine Hcl	Paroxetine Hcl	91	19
Triamcinolone Acetonide	Triamcinolone Acetonide	88	27
Lidocaine	Lidocaine	86	14
Warfarin Sodium	Warfarin Sodium	83	24
Klor-Con M10	Potassium Chloride	82	25
Escitalopram Oxalate	Escitalopram Oxalate	80	22
Zolpidem Tartrate	Zolpidem Tartrate	80	15
Chlorthalidone	Chlorthalidone	79	19
Quetiapine Fumarate	Quetiapine Fumarate	79	17
Ventolin Hfa	Albuterol Sulfate	77	26
Ozempic	Semaglutide	76	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	74	20
Memantine Hcl	Memantine Hcl	73	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	69	11
Sumatriptan Succinate	Sumatriptan Succinate	68	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	66	56
Pregabalin	Pregabalin	64	suppressed
Azithromycin	Azithromycin	62	57
Bupropion Xl	Bupropion Hcl	62	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	18
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	59	13
Breo Ellipta	Fluticasone/Vilanterol	56	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	56	43
Gemfibrozil	Gemfibrozil	55	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	53	suppressed
Clonidine Hcl	Clonidine Hcl	53	14
Nifedipine Er	Nifedipine	53	17
Nystatin	Nystatin	53	20
Propranolol Hcl	Propranolol Hcl	53	16
Ropinirole Hcl	Ropinirole Hcl	52	12
Xarelto	Rivaroxaban	52	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	51	15
Glimepiride	Glimepiride	50	13
Venlafaxine Hcl Er	Venlafaxine Hcl	50	11
Alcohol Pads	Alcohol Antiseptic Pads	49	suppressed
Alprazolam	Alprazolam	49	suppressed
Baclofen	Baclofen	49	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	49	23
Fenofibrate	Fenofibrate Nanocrystallized	49	11
Lovastatin	Lovastatin	48	14
Bupropion Hcl Sr	Bupropion Hcl	46	suppressed
Finasteride	Finasteride	46	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	46	15
Irbesartan	Irbesartan	45	12
Fluticasone Propionate Hfa	Fluticasone Propionate	44	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	11
Wixela Inhub	Fluticasone Propion/Salmeterol	43	14
Folic Acid	Folic Acid	42	suppressed
Topiramate	Topiramate	41	11
Novolog Flexpen	Insulin Aspart	39	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Labetalol Hcl	Labetalol Hcl	37	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Naproxen	Naproxen	36	16
Clotrimazole	Clotrimazole	35	15
Mupirocin	Mupirocin	35	27
Doxycycline Hyclate	Doxycycline Hyclate	34	31
Metoclopramide Hcl	Metoclopramide Hcl	34	suppressed
Lactulose	Lactulose	32	suppressed
Loperamide	Loperamide Hcl	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Torsemide	Torsemide	32	11
Verapamil Er	Verapamil Hcl	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Fluconazole	Fluconazole	30	17
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Clobetasol Propionate	Clobetasol Propionate	29	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	16
Advair Hfa	Fluticasone Propion/Salmeterol	28	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	suppressed
Linzess	Linaclotide	27	suppressed
Roflumilast	Roflumilast	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	22
Synthroid	Levothyroxine Sodium	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Lacosamide	Lacosamide	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Cephalexin	Cephalexin	23	22
Diltiazem Hcl	Diltiazem Hcl	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	16
Colchicine	Colchicine	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Estradiol	Estradiol	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Trulance	Plecanatide	19	suppressed
Unifine Pentips	Pen Needle, Diabetic	19	suppressed
Clonidine	Clonidine	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Epinephrine	Epinephrine	18	11
Felodipine Er	Felodipine	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Indapamide	Indapamide	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Benzonatate	Benzonatate	17	12
Lansoprazole	Lansoprazole	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Diazepam	Diazepam	13	suppressed
Ethosuximide	Ethosuximide	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Single Use Swab	Alcohol Antiseptic Pads	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Phenytoin	Phenytoin	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$80.20 · 3 records	Exact Sciences Corporation	CREON, Cologuard Collection Kit, MOUNJARO, ZEPBOUND	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error